<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">NCP</journal-id>
<journal-id journal-id-type="hwp">spncp</journal-id>
<journal-id journal-id-type="nlm-ta">Nutr Clin Pract</journal-id>
<journal-title>Nutrition in Clinical Practice</journal-title>
<issn pub-type="ppub">0884-5336</issn>
<issn pub-type="epub">1941-2452</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0884533612469059</article-id>
<article-id pub-id-type="publisher-id">10.1177_0884533612469059</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Observations</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Thiamine Deficiency Following Umbilical Cord Blood Transplant</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Trueg</surname><given-names>Anne</given-names></name>
<degrees>PharmD</degrees>
<xref ref-type="aff" rid="aff1-0884533612469059">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Borho</surname><given-names>Teri</given-names></name>
<degrees>RD</degrees>
<xref ref-type="aff" rid="aff2-0884533612469059">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Srivastava</surname><given-names>Shivani</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-0884533612469059">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kiel</surname><given-names>Patrick</given-names></name>
<degrees>PharmD</degrees>
<xref ref-type="aff" rid="aff1-0884533612469059">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0884533612469059"><label>1</label>Indiana University Health Simon Cancer Center, Indianapolis, Indiana</aff>
<aff id="aff2-0884533612469059"><label>2</label>Indiana University Health, Frankfort, Indiana</aff>
<aff id="aff3-0884533612469059"><label>3</label>Indiana University School of Medicine, Indianapolis, Indiana</aff>
<author-notes>
<corresp id="corresp1-0884533612469059">Anne Trueg, Indiana University Health Simon Cancer Center, 550 N University Blvd, Indianapolis, IN 46202, USA. Email: <email>atrueg@iuhealth.org</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>2</issue>
<issue-title>Research and Publishing</issue-title>
<fpage>223</fpage>
<lpage>225</lpage>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p>A case of Wernicke encephalopathy (WE) in the setting of umbilical cord blood transplant is reported. The patient, originally diagnosed with Philadelphia chromosome–positive acute lymphoblastic leukemia, proceeded to an umbilical cord blood transplant. He presented with altered mental status 149 days following transplant. Prompt magnetic resonance imaging, baseline thiamine level, and immediate intravenous replacement allowed for recovery of most symptoms. Accompanying this case is a review of the known cases of WE in hematopoietic cell transplants and their causative factors. This is the first known adult case of WE independent of parenteral nutrition use in the setting of umbilical cord transplant.</p>
</abstract>
<kwd-group>
<kwd>enteral nutrition</kwd>
<kwd>thiamine</kwd>
<kwd>thiamine deficiency</kwd>
<kwd>transplant</kwd>
<kwd>transplantation</kwd>
<kwd>Wernicke encephalopathy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Thiamine is a water-soluble vitamin also known as vitamin B<sub>1</sub>. Thiamine deficiency can present as a central nervous system disorder known as Wernicke encephalopathy (WE), which classically manifests as confusion, ataxia, and opthalmoplegia.<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup> Thiamine acts as a cofactor to enzymes that metabolize carbohydrates, fats, amino acids, glucose, and alcohol.<sup><xref ref-type="bibr" rid="bibr2-0884533612469059">2</xref></sup></p>
<p>Risk factors for thiamine deficiency include diets rich in white rice and highly refined carbohydrates, chronic excessive alcohol use, hypermetabolic states such as hyperthyroidism or fever, or impaired absorption in prolonged diarrhea.<sup><xref ref-type="bibr" rid="bibr2-0884533612469059">2</xref></sup> The human body can store between 30 and 50 mg of thiamine; regular carbohydrate intake uses 1–2 mg of thiamine per day, but increased carbohydrate intake through alcohol or dextrose-containing solutions increases daily thiamine requirements.<sup><xref ref-type="bibr" rid="bibr3-0884533612469059">3</xref></sup> In these situations, deficiency can occur within 2–3 weeks of restriction and is a neurologic emergency. Prompt repletion can avert permanent neurologic damage.<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup> Without a high index of suspicion, this disorder can go undiagnosed until autopsy. Here, we present a case of WE following cord blood transplant.</p>
<sec id="section1-0884533612469059" sec-type="cases">
<title>Case</title>
<p>A 34-year-old African American man presented with a pulmonary embolism in December 2010 and was subsequently diagnosed with Philadelphia chromosome–positive acute lymphoblastic leukemia. The patient underwent induction therapy with imatinib 400 mg daily and 8 cycles of hyper-fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD) and then proceeded to an umbilical cord blood transplant in March 2011 in complete remission. His conditioning regimen included total-body irradiation for 3 days prior to cell infusion, cyclophosphamide 1800 mg/m<sup>2</sup> intravenously (IV) for 2 days prior to cell infusion, and fludarabine 30 mg/m<sup>2</sup> IV for 3 days prior to cell infusion.</p>
<p>The patient received tacrolimus and sirolimus as graft vs host disease (GVHD) prophylaxis until 112 days after transplant, when he was diagnosed with acute GVHD, stage III of IV, of the gut. The patient was then treated with methylprednisolone 2 mg/kg orally daily, budesonide 9 mg orally daily, mycophenolate mofetil 1000 mg orally twice daily, and sirolimus 1 mg orally daily with adequate response.</p>
<p>One hundred forty-nine days following transplant, the patient was admitted to the hospital after presenting to the clinic obtunded and incontinent of urine and stool, with family members reporting the patient to be having hallucinations. Vitals and laboratory values on admission are listed in <xref ref-type="table" rid="table1-0884533612469059">Table 1</xref>. Relevant medications on admission included acyclovir 400 mg twice a day, voriconazole 200 mg twice a day, dapsone 100 mg daily, sirolimus 1 mg daily, budesonide 9 mg daily, methylprednisolone 72 mg every morning and 36 mg every evening, folic acid 1 mg daily, and 1 L normal saline + 40 mEq potassium chloride + 1 g magnesium sulfate daily.</p>
<table-wrap id="table1-0884533612469059" position="float">
<label>Table 1.</label>
<caption>
<p>Laboratory Values of Case Patient on Admission for Wernicke’s Encephalopathy</p>
</caption>
<graphic alternate-form-of="table1-0884533612469059" xlink:href="10.1177_0884533612469059-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center">Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="2"><bold>Vitals</bold></td>
</tr>
<tr>
<td> Blood pressure</td>
<td>147/89 mm Hg</td>
</tr>
<tr>
<td> Temperature</td>
<td>36.4°C</td>
</tr>
<tr>
<td> Heart rate</td>
<td>100 bpm</td>
</tr>
<tr>
<td colspan="2"><bold>Complete blood count</bold></td>
</tr>
<tr>
<td> White blood cell</td>
<td>24.3 × 10<sup>9</sup>/L</td>
</tr>
<tr>
<td> Hemoglobin</td>
<td>8.6 g/dL</td>
</tr>
<tr>
<td> Platelet</td>
<td>51 × 10<sup>9</sup>/L</td>
</tr>
<tr>
<td colspan="2"><bold>Chemistry</bold></td>
</tr>
<tr>
<td> Sodium</td>
<td>134 mmol/L</td>
</tr>
<tr>
<td> Potassium</td>
<td>4 mmol/L</td>
</tr>
<tr>
<td> Creatinine kinase</td>
<td>223 U/L</td>
</tr>
<tr>
<td> Serum creatinine</td>
<td>1.2 mg/dL</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Workup included a physical exam and magnetic resonance imaging (MRI), which demonstrated bilateral T2 hyperintensity of the mammillary bodies, periatrial gray matter, and medial thalami. Differential diagnosis at this time included human herpesvirus-6, toxicity from prophylactic intrathecal methotrexate given 1 week prior to admission, toxicity from steroid taper, thiamine deficiency, or cord colitis syndrome. A serum B<sub>1</sub> concentration was obtained and was found to be low: 54 nmol/L (80–150 nmol/L); folate and B<sub>12</sub> levels were within normal range.</p>
<p>On the basis of these findings, the patient was started on thiamine 100 mg IV daily for 1 week, then thiamine 100 mg by mouth daily. The patient was discharged with resolution of confusion. Follow-up thiamine levels indicated effective replacement (<xref ref-type="table" rid="table2-0884533612469059">Table 2</xref>). Two months following thiamine replacement at clinic follow-up, the patient was conversant with improvement in personality; however, the patient remained forgetful without complete resolution of symptoms from baseline.</p>
<table-wrap id="table2-0884533612469059" position="float">
<label>Table 2.</label>
<caption>
<p>Serum Thiamine Concentrations of Case Patient Throughout Recovery</p>
</caption>
<graphic alternate-form-of="table2-0884533612469059" xlink:href="10.1177_0884533612469059-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Thiamine Concentration (Normal: 70–180 nmol/L), nmol/L</th>
<th align="center">Days From Transplant</th>
</tr>
</thead>
<tbody>
<tr>
<td>54</td>
<td>151</td>
</tr>
<tr>
<td>234</td>
<td>158</td>
</tr>
<tr>
<td>151</td>
<td>172</td>
</tr>
<tr>
<td>216</td>
<td>176</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section2-0884533612469059" sec-type="discussion">
<title>Discussion</title>
<p>The initial signs and symptoms of WE are nonspecific. WE is rare in developed countries, where thiamine is supplemented in many food sources. Thiamine deficiency is most common when these sources are absent from the diet. Glucose-containing IV solutions or parenteral nutrition (PN) without thiamine repletion can quickly lead to thiamine deficiency and WE.<sup><xref ref-type="bibr" rid="bibr2-0884533612469059">2</xref></sup> Thiamine metabolism is increased when carbohydrate metabolism is increased, thus necessitating the need to empirically replete thiamine.<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></p>
<p>Hematopoietic cell transplant (HCT) patients often have multiple sources for neurologic changes, which makes diagnosing WE difficult without a high index of suspicion.<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup> Medications used to prevent GVHD, infectious processes, cerebrovascular insults, or metabolic changes are all high in the differential in a patient with confusion or neurological complications undergoing HCT.<sup><xref ref-type="bibr" rid="bibr5-0884533612469059">5</xref></sup> These patients often receive PN or dextrose IV solutions, which put them at risk for thiamine deficiency if not effectively replaced. Prompt imaging of the brain with MRI is the best way to identify WE.<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup> Images of the brain traditionally demonstrate T2 hyperintensity in the preventricular regions of the thalamus, hypothalamus, mammillary bodies, and periaqueductal region of the midbrain.</p>
<p>Thirty cases of WE in HCT patients have been reported in the literature (<xref ref-type="table" rid="table3-0884533612469059">Table 3</xref>). Ten of these were adult patients who all received PN with the standard multivitamin (MVI) but without additional thiamine replacement. These patients received PN for a mean of 20 days prior to initial symptoms of WE. Four of the 30 patients were pediatric patients whose diets were identified as deficient in thiamine. One of these 4 received PN with MVI without additional thiamine replacement, 1 received IV glucose for 4 weeks prior to symptoms, and the remaining 2 depended mainly on soft drinks and other highly refined carbohydrate caloric intake.</p>
<table-wrap id="table3-0884533612469059" position="float">
<label>Table 3.</label>
<caption>
<p>Review of Wernicke’s Encephalopathy Cases in the Literature and Their Outcomes</p>
</caption>
<graphic alternate-form-of="table3-0884533612469059" xlink:href="10.1177_0884533612469059-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Case</th>
<th align="center">Author</th>
<th align="center">Adult/ Pediatric</th>
<th align="center">Parenteral Nutrition Use</th>
<th align="center">Thiamine Replaced</th>
<th align="center">Outcome</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Kuo et al<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>Yes</td>
<td>Improved mental status</td>
</tr>
<tr>
<td>2</td>
<td>Kuo et al<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>3</td>
<td>Kuo et al<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>4</td>
<td>Kuo et al<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>5</td>
<td>Kuo et al<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>6</td>
<td>Messina et al<sup><xref ref-type="bibr" rid="bibr2-0884533612469059">2</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>Yes</td>
<td>Improved mental status</td>
</tr>
<tr>
<td>7</td>
<td>Messina et al<sup><xref ref-type="bibr" rid="bibr2-0884533612469059">2</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>Yes</td>
<td>Improved mental status</td>
</tr>
<tr>
<td>8</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>9</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>10</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>11</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>12</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>13</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>14</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>15</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>16</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>17</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr4-0884533612469059">4</xref></sup></td>
<td>Adult</td>
<td>Unknown</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>18</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>19</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>20</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>21</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>22</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>23</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>24</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>25</td>
<td>Bleggi-Torres et al<sup><xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>26</td>
<td>Baek et al<sup><xref ref-type="bibr" rid="bibr7-0884533612469059">7</xref></sup></td>
<td>Adult</td>
<td>Yes</td>
<td>Yes</td>
<td>Improved mental status</td>
</tr>
<tr>
<td>27</td>
<td>Mohrmann et al<sup><xref ref-type="bibr" rid="bibr8-0884533612469059">8</xref></sup></td>
<td>Pediatric</td>
<td>Yes</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>28</td>
<td>Pihko et al<sup><xref ref-type="bibr" rid="bibr9-0884533612469059">9</xref></sup></td>
<td>Pediatric</td>
<td>No</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>29</td>
<td>Pihko et al<sup><xref ref-type="bibr" rid="bibr9-0884533612469059">9</xref></sup></td>
<td>Pediatric</td>
<td>No</td>
<td>No</td>
<td>Death</td>
</tr>
<tr>
<td>30</td>
<td>Shah and Wolff<sup><xref ref-type="bibr" rid="bibr10-0884533612469059">10</xref></sup></td>
<td>Pediatric</td>
<td>No</td>
<td>Yes</td>
<td>Improved mental status</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The use of PN or glucose-containing solutions was not specified in the final 15 case reports of WE in HCT patients.<sup><xref ref-type="bibr" rid="bibr1-0884533612469059">1</xref>,<xref ref-type="bibr" rid="bibr6-0884533612469059">6</xref></sup> In the case presented here, PN with MVI and thiamine supplementation was used for 10 days while the patient awaited engraftment, roughly 100 days prior to the signs and symptoms of WE.</p>
<p>The causative factor in this patient’s WE is unknown. Prior to the diagnosis of WE, the patient experienced prolonged poor oral nutrient intake with a 25-kg weight loss within the first 3 months after transplant. Leading up to the diagnosis of WE, his precise oral intake is unknown due to lack of nutrition follow-up in the posttransplant outpatient setting at our institution. The presence of gut GVHD may have contributed to the development of WE through malabsorption, decreased appetite, and nausea or vomiting. Decreased nutrition intake and malabsorption are common issues in patients with gut GVHD. As such, it is important that outpatient screening of nutrition intake and thiamine levels in these patients be assessed. Implementing outpatient dietician support in the clinic would provide additional resources to help prospectively assess nutrition status.</p>
<p>To our knowledge, this is the first case report of WE in an adult umbilical cord blood transplant patient independent of PN use. WE is a rare but fatal disorder without prompt recognition and treatment; all patients in the literature who received additional thiamine replacement achieved restoration of mental status. All patients receiving prolonged PN or glucose-containing IV solutions should receive thiamine replacement in addition to MVI. Patients in the post-HCT setting with neurologic changes and decreased nutrient intake and absorption should be worked up for WE as this disorder is largely reversible if caught early.<sup><xref ref-type="bibr" rid="bibr11-0884533612469059">11</xref></sup></p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: None declared.</p>
</fn>
<fn fn-type="other">
<p>This article originally appeared online on December 13, 2012.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0884533612469059">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuo</surname><given-names>SH</given-names></name>
<name><surname>Debnam</surname><given-names>JM</given-names></name>
<name><surname>Fuller</surname><given-names>GN</given-names></name>
<name><surname>de Groot</surname><given-names>J</given-names></name>
</person-group>. <article-title>Wernicke’s encephalopathy: an underrecognized and reversible cause of confusional state in cancer patients</article-title>. <source>Oncology</source>. <year>2009</year>;<volume>76</volume>:<fpage>10</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr2-0884533612469059">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Messina</surname><given-names>G</given-names></name>
<name><surname>Quartarone</surname><given-names>E</given-names></name>
<name><surname>Console</surname><given-names>G</given-names></name><etal/>
</person-group>. <article-title>Wernicke’s encephalopathy after allogeneic stem cell transplantations</article-title>. <source>Tumori</source>. <year>2007</year>;<volume>93</volume>:<fpage>207</fpage>-<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr3-0884533612469059">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thomson</surname><given-names>AD</given-names></name>
<name><surname>Guerrini</surname><given-names>I</given-names></name>
<name><surname>Marshall</surname><given-names>EJ</given-names></name>
</person-group>. <article-title>Wernicke’s encephalopathy: the role of thiamine</article-title>. <source>Pract Gastro</source>. <month>June</month> <volume>2009</volume>:<fpage>21</fpage>-<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr4-0884533612469059">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bleggi-Torres</surname><given-names>LF</given-names></name>
<name><surname>de Medeiros</surname><given-names>BC</given-names></name>
<name><surname>Werner</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases</article-title>. <source>Bone Marrow Transplant</source>. <year>2000</year>;<volume>25</volume>:<fpage>301</fpage>-<lpage>307</lpage>.</citation>
</ref>
<ref id="bibr5-0884533612469059">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Snider</surname><given-names>S</given-names></name>
<name><surname>Bashir</surname><given-names>R</given-names></name>
<name><surname>Bierman</surname><given-names>P</given-names></name>
</person-group>. <article-title>Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin’s disease</article-title>. <source>Neurology</source>. <year>1994</year>;<volume>44</volume>:<fpage>681</fpage>-<lpage>684</lpage>.</citation>
</ref>
<ref id="bibr6-0884533612469059">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bleggi-Tores</surname><given-names>LF</given-names></name>
<name><surname>de Medeiros</surname><given-names>BC</given-names></name>
<name><surname>Ogasawara</surname><given-names>VSA</given-names></name>
<etal/></person-group>. <article-title>Iatrogenic Wernicke’s encephalopathy in allogeneic bone marrow transplantation: a study of eight cases</article-title>. <source>Bone Marrow Transplant</source>. <year>1997</year>;<volume>20</volume>:<fpage>391</fpage>-<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr7-0884533612469059">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Baek</surname><given-names>JH</given-names></name>
<name><surname>Sohn</surname><given-names>SK</given-names></name>
<name><surname>Kim</surname><given-names>DH</given-names></name>
<etal/></person-group>. <article-title>Wernicke’s encephalopathy after allogeneic stem transplantation</article-title>. <source>Bone Marrow Transplant</source>. <year>2005</year>;<volume>35</volume>:<fpage>829</fpage>-<lpage>830</lpage>.</citation>
</ref>
<ref id="bibr8-0884533612469059">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mohrmann</surname><given-names>RL</given-names></name>
<name><surname>Mah</surname><given-names>V</given-names></name>
<name><surname>Vinters</surname><given-names>HV</given-names></name>
</person-group>. <article-title>Neuropathologic findings after bone marrow transplantation: an autopsy study</article-title>. <source>Hum Pathol</source>. <year>1990</year>;<volume>21</volume>: <fpage>630</fpage>-<lpage>639</lpage>.</citation>
</ref>
<ref id="bibr9-0884533612469059">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pihko</surname><given-names>H</given-names></name>
<name><surname>Saarinen</surname><given-names>U</given-names></name>
<name><surname>Paetau</surname><given-names>A</given-names></name>
</person-group>. <article-title>Wernicke encephalopathy—preventable cause of death: report of 2 children with malignant disease</article-title>. <source>Pediatr Neurol</source>. <year>1989</year>;<volume>5</volume>:<fpage>237</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr10-0884533612469059">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shah</surname><given-names>N</given-names></name>
<name><surname>Wolff</surname><given-names>J</given-names></name>
</person-group>. <article-title>Thiamine deficiency: probably Wernicke’s encephalopathy successfully treated in a child with acute lymphocytic leukemia</article-title>. <source>Pediatrics</source>. <year>1973</year>;<volume>51</volume>:<fpage>750</fpage>-<lpage>751</lpage>.</citation>
</ref>
<ref id="bibr11-0884533612469059">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Herrera</surname><given-names>AF</given-names></name>
<name><surname>Soriano</surname><given-names>G</given-names></name>
<name><surname>Bellizzi</surname><given-names>AM</given-names></name>
<etal/></person-group>. <article-title>Cord colitis syndrome in cord-blood stem-cell transplantation</article-title>. <source>N Engl J Med</source>. <year>2011</year>;<volume>365</volume>:<fpage>815</fpage>-<lpage>824</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>